CAS: 1795037-48-7

Applications Labelled Rufinamide (R701552). Antiepileptic triazole derivative which decreases firing by neurons at sodium channels. Anticonvulsant. References Cheung, W.K., et al.: Pharm. Res., 12, 1878 (1995), Cardot, J.-M., et al.: Biopharm. Drug Dispos., 19, 259 (1998), Palhagen, S., et al.: Epilepsy Res., 43, 115 (2001),

Rufinamide-15N-d2 is a medicinal compound that has been shown to exhibit inhibitory activity against tumor cells in human cancer cell lines. It works by targeting specific proteins involved in the growth and proliferation of cancer cells, leading to their death. Rufinamide-15N-d2 is a promising candidate for the development of new cancer inhibitors due to its ability to selectively target cancer cells while leaving healthy cells unharmed. This compound has been extensively studied in vitro and in vivo, demonstrating its potential as a powerful tool in the fight against cancer. Its effectiveness against different types of tumors makes it an excellent option for those seeking alternative treatments for their condition.